Download PDF
Semin Liver Dis 2002; 22(2): 195-206
DOI: 10.1055/s-2002-30104
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Herbal Hepatotoxicity

Catherine Stedman
  • Department of Clinical Pharmacology and Storr Liver Unit, Westmead Millennium Institute, University of Sydney at Westmead Hospital, New South Wales, Australia
Further Information

Publication History

Publication Date:
16 May 2002 (online)

    Permissions and Reprints

ABSTRACT

Herbal hepatotoxicity is increasingly recognized as herbal medicines become more popular in industrialized societies. Some herbal products may potentially benefit people with liver disease; however, these benefits remain generally unproved in humans, and a greater awareness of potential adverse effects is required. Herbal use is often not disclosed, and this may result in a diagnostic delay and perpetuation or exacerbation of liver injury. Female gender may predispose to hepatotoxicity, and concomitant agents that induce cytochrome P450 enzymes may also increase individual susceptibility. The range of liver injury includes minor transaminase elevations, acute and chronic hepatitis, steatosis, cholestasis, zonal or diffuse hepatic necrosis, hepatic fibrosis and cirrhosis, veno-occlusive disease, and acute liver failure requiring transplantation. In addition to the potential for hepatotoxicity, drug-drug interactions between herbal medicines and conventional agents may affect the efficacy and safety of concurrent medical therapy. This review focuses on emerging hepatotoxins and patterns of liver injury, potential risk factors for herbal hepatotoxicity, and herb-drug interactions. Appropriate reporting and regulatory systems to monitor herbal toxicity are required, in conjunction with ongoing scientific evaluation of the potential benefits of phytotherapy.

KEYWORDS

Herbal medicine - Chinese herbal drugs - liver injury - drug-drug interactions

REFERENCES

  • 1 Kessler R C, Davis R B, Foster D F. Long-term trends in the use of complementary and alternative medical therapies in the United States.  Ann Intern Med . 2001;  135 262-268
    PubMedGoogle Scholar
  • 2 Seef L B, Lindsay K L, Bacon B R. Complementary and alternative medicine in chronic liver disease.  Hepatology . 2001;  34 595-603
    CrossrefPubMedGoogle Scholar
  • 3 Berk B S, Chaya C, Benner K C, Flora K D. Comparison of herbal therapy for liver disease: 1996 versus 1999.  Hepatology . 1999;  30 478A
    PubMedGoogle Scholar
  • 4 Schuppan D, Jia J-D, Brinkhaus B, Hahn E G. Herbal products for liver diseases: a therapeutic challenge for the new millennium.  Hepatology . 1999;  30 1099-1104
    CrossrefPubMedGoogle Scholar
  • 5 Eisenberg D M, Kessler R C, Van Rompay I M. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey.  Ann Intern Med . 2001;  135 344-351
    CrossrefPubMedGoogle Scholar
  • 6 Borum M L. Fulminant exacerbation of autoimmune hepatitis after the use of Ma huang.  Am J Gastroenterol . 2001;  96 1654-1655
    CrossrefPubMedGoogle Scholar
  • 7 Kamiyama T, Nouchi T, Kojima S. Autoimmune hepatitis triggered by administration of an herbal medicine.  Am J Gastroenterol . 1997;  92 703-704
    PubMedGoogle Scholar
  • 8 Fau D, Lekehal M, Farrell G. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes.  Gastroenterology . 1997;  113 1334-1346
    CrossrefPubMedGoogle Scholar
  • 9 Kaplowitz N. Hepatotoxicity of herbal remedies: insights into the intricacies of plant-animal warfare and cell death.  Gastroenterology . 1997;  113 1408-1409
    PubMedGoogle Scholar
  • 10 Haouzi D, Lekehal M, Moreau A. Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes.  Hepatology . 2000;  32 303-311
    CrossrefPubMedGoogle Scholar
  • 11 Cheng T O. Warfarin danshen interaction.  Ann Thorac Surg . 1999;  67 892-896
    PubMedGoogle Scholar
  • 12 Fugh-Berman A. Herb-drug interactions.  Lancet . 2000;  355 134-138
    CrossrefPubMedGoogle Scholar
  • 13 Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements: a five year toxicological study.  Drug Saf . 1997;  17 342-356
    PubMedGoogle Scholar
  • 14 Page R L, Lawrence J D. Potentiation of warfarin by dong quai.  Pharmacotherapy . 1999;  19 870-876
    CrossrefPubMedGoogle Scholar
  • 15 Ellis G R, Stephens M R. Untitled (photographs and brief case report).  BMJ . 1999;  319 650
    PubMedGoogle Scholar
  • 16 Miller L G. Herbal medicinals: selected clinical considerations focussing on known or potential drug-herb interactions.  Arch Intern Med . 1998;  158 2200-2211
    CrossrefPubMedGoogle Scholar
  • 17 Rose K D, Croissant P D, Parliament C F, Levin M B. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report.  Neurosurgery . 1990;  26 880-882
    PubMedGoogle Scholar
  • 18 Lamant V, Mauco G, Braquet P. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.  Biochem Pharmacol . 1987;  36 2749-2752
    CrossrefPubMedGoogle Scholar
  • 19 Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba Lancet .  1998;  352 36
    PubMedGoogle Scholar
  • 20 Fessenden J M, Wittenborn W, Clarke L. Ginkgo biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy.  Am Surg . 2001;  67 33-35
    PubMedGoogle Scholar
  • 21 Skogh M. Extracts of Ginkgo biloba and bleeding or haemorrhage.  Lancet . 1998;  352 1145-1146
    PubMedGoogle Scholar
  • 22 Janetzky K, Morreale A P. Probable interaction between warfarin and ginseng.  Am J Health Syst Pharm . 1997;  54 692-693
    PubMedGoogle Scholar
  • 23 Yue Q-Y, Bergquist C, Gerden B. Safety of St John's wort (Hypericum perforatum).  Lancet . 2000;  355 576-577
    CrossrefPubMedGoogle Scholar
  • 24 Mustapha A, Yakasai I A, Aguye I A. Effect of Tamarindus indica L. on the bioavailability of aspirin in healthy human volunteers.  Eur J Drug Metab Pharmacokinet . 1996;  21 223-226
    PubMedGoogle Scholar
  • 25 Karliova M, Treichel U, Malago M. Interaction of Hypericum perforatum (St John's wort) with cyclosporin A metabolism in a patient after liver transplantation.  J Hepatol . 2000;  33 853-855
    CrossrefPubMedGoogle Scholar
  • 26 Stickel F, Egerer G, Seitz H K. Hepatotoxicity of botanicals.  Public Health Nutr . 2000;  3 113-124
    PubMedGoogle Scholar
  • 27 Loeper J, Descatoire V, Letteron P. Hepatotoxicity of germander in mice.  Gastroenterology . 1994;  106 464-472
    PubMedGoogle Scholar
  • 28 Chen M F, Shimada F, Kato H. Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone.  Endocrinol Jpn . 1991;  38 167-174
    PubMedGoogle Scholar
  • 29 Homma M, Oka K, Ikeshima K. Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics.  J Pharm Pharmacol . 1995;  47 687-692
    PubMedGoogle Scholar
  • 30 Moore L B, Goodwin B, Jones S A. St John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.  Proc Natl Acad Sci USA . 2000;  97 7500-7502
    CrossrefPubMedGoogle Scholar
  • 31 Durr D, Stieger B, Kullak-Ublick G A. St John's wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4.  Clin Pharmacol Ther . 2000;  68 598-604
    CrossrefPubMedGoogle Scholar
  • 32 Chitturi S, Farrell G. Herbal hepatotoxicity: an expanding but poorly defined problem.  J Gastroenterol Hepatol . 2000;  15 1093-1099
    CrossrefPubMedGoogle Scholar
  • 33 Larrey D. Hepatotoxicity of herbal remedies.  J Hepatol . 1997;  26 47-51
    CrossrefPubMedGoogle Scholar
  • 34 Farrell G C, Weltman M. Drug-induced liver disease. In: Gitnick G, ed. Current Hepatology, vol 16 Chicago: Mosby- Year Book Medical Publishers 1996: 143-208
    Google Scholar
  • 35 Farrell G C. Drug-Induced Liver Disease.  Edinburgh: Churchill Livingstone 1994: 513-518
    Google Scholar
  • 36 Uc A, Bishop W P, Sanders K D. Camphor hepatotoxicity.  South Med J . 2000;  93 596-598
    CrossrefPubMedGoogle Scholar
  • 37 Jimenez J F, Brown A L, Arnold W C, Byrne W J. Chronic camphor ingestion mimicking Reye's syndrome.  Gastroenterology . 1983;  84 394-398
    PubMedGoogle Scholar
  • 38 Lin Y F, Lin S H. Simultaneous acute renal and hepatic failure after ingesting raw carp gall bladder.  Nephrol Dial Transplant . 1999;  14 2011-2012
    PubMedGoogle Scholar
  • 39 Nadir A, Reddy D, Van Thiel H D. Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity.  Am J Gastroenterol . 2000;  95 3634-3637
    CrossrefPubMedGoogle Scholar
  • 40 Sheikh N M, Philen R M, Love L A. Chaparral-associated hepatotoxicity.  Arch Intern Med . 1997;  157 913-919
    CrossrefPubMedGoogle Scholar
  • 41 Batchelor W B, Heathcote J, Wanless I R. Chaparral-induced hepatic injury.  Am J Gastroenterol . 1995;  90 831-832
    PubMedGoogle Scholar
  • 42 Kane J A, Kane S P, Jain S. Hepatitis induced by traditional Chinese herbs; possible toxic components.  Gut . 1995;  36 146-147
    CrossrefPubMedGoogle Scholar
  • 43 Yoshida E M, McLean C A, Cheng E S. Chinese herbal medicine, fulminant hepatitis and liver transplantation (letter).  Am J Gastroenterol . 1996;  91 2647-2648
    PubMedGoogle Scholar
  • 44 Itoh S, Marutani K, Nishijima T. Liver injuries induced by herbal medicine, syo-saiko-to (xiao-chai-hu-tang).  Dig Dis Sci . 1995;  40 1845-1848
    PubMedGoogle Scholar
  • 45 Benninger J, Schneider H T, Schuppan D. Acute hepatitis induced by greater celandine (Chelidonium majus).  Gastroenterology . 1999;  117 1234-1237
    CrossrefPubMedGoogle Scholar
  • 46 Mostefa-Kara N, Pauwels A, Pines E. Fatal hepatitis after herbal tea (letter).  Lancet . 1992;  340 674
    CrossrefPubMedGoogle Scholar
  • 47 Larrey D, Vial T, Pauwels A. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity.  Ann Intern Med . 1992;  117 129-132
    PubMedGoogle Scholar
  • 48 Popat A, Shear N H, Malkiewicz I. The toxicity of Callilepis laureola, a South African traditional herbal medicine.  Clin Biochem . 2001;  34 229-236
    CrossrefPubMedGoogle Scholar
  • 49 Fraquelli M, Colli A, Cocciolo M, Conte D. Adult syncytial giant cell chronic hepatitis due to herbal remedy.  J Hepatol . 2000;  33 505-508
    CrossrefPubMedGoogle Scholar
  • 50 Picciotto A, Campo N, Brizzolara R. Chronic hepatitis induced by Jin Bu Huan.  J Hepatol . 1998;  28 165-167
    PubMedGoogle Scholar
  • 51 Horowitz R S, Feldhaus K, Dart R C. The clinical spectrum of Jin Bu Huan toxicity.  Arch Intern Med . 1996;  156 899-903
    CrossrefPubMedGoogle Scholar
  • 52 Woolf G M, Petrovic L M, Rojter S E. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan.  Ann Intern Med . 1994;  121 729-735
    CrossrefPubMedGoogle Scholar
  • 53 Escher M, Desmeales J, Giostra E, Mentha G. Hepatitis associated with Kava, a herbal remedy for anxiety.  BMJ . 2001;  322 139
    PubMedGoogle Scholar
  • 54 Kraft M, Spahn T W, Menzel J. Fulminantes Leberversagen nach Einnahme des pflanzlichen antidepressivums kava-kava.  Dtsch Med Wochenschr . 2001;  126 970-972
    Article in Thieme ConnectPubMedGoogle Scholar
  • 55 Russmann S, Lauterburg B H, Helbling A. Kava hepatotoxicity.  Ann Intern Med . 2001;  135 68-69
    PubMedGoogle Scholar
  • 56 Perron A D, Patterson J A, Yanofsky N N. Kombucha ``mushroom'' hepatotoxicity (letter).  Ann Emerg Med . 1995;  26 660-661
    PubMedGoogle Scholar
  • 57 Tolman K G, Hammar S, Sannella J J. Possible hepatotoxicity of Doxidan.  Ann Intern Med . 1976;  84 290-292
    PubMedGoogle Scholar
  • 58 Beuers U, Spengler V, Pape G R. Hepatitis after chronic abuse of senna (letter).  Lancet . 1991;  37 372
    PubMedGoogle Scholar
  • 59 Woolf G M. Senna-induced hepatotoxicity.  Hepatology . 1999;  550A 1560
    PubMedGoogle Scholar
  • 60 Nadir A, Agarwal S, King P D, Marshall J B. Acute hepatitis associated with the use of a Chinese herbal product, Ma-huang.  Am J Gastroenterol . 1996;  91 1436-1438
    PubMedGoogle Scholar
  • 61 Stewart M J, Steenkamp V. The biochemistry and toxicity of atractyloside: a review.  Ther Drug Monit . 2000;  22 641-649
    CrossrefPubMedGoogle Scholar
  • 62 Mattei A, Rucay P, Samuel D. Liver transplantation for acute liver failure after herbal medicine (Teucrium polium) administration (letter).  J Hepatol . 1995;  22 597
    PubMedGoogle Scholar
  • 63 Harvey J, Colin-Jones D G. Mistletoe hepatitis.  BMJ . 1981;  282 1050-1054
    PubMedGoogle Scholar
  • 64 Harvey J, Colin-Jones D G. Mistletoe hepatitis.  Br Med J (Clin Res Ed) . 1981;  282 186-187
    CrossrefPubMedGoogle Scholar
  • 65 Anderson I B, Mullen W H, Meeker J E. Pennyroyal toxicity: measurement of toxic metabolites in two cases and review of the literature.  Ann Intern Med . 1996;  124 726-734
    PubMedGoogle Scholar
  • 66 Bakerink J A, Gosper S M, Dimand R J, Eldridge M W. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants.  Pediatrics . 1996;  98 944-947
    PubMedGoogle Scholar
  • 67 Hamid S, Rojter S, Vierling J. Protracted cholestatic hepatitis after the use of Prostata (letter).  Ann Intern Med . 1997;  127 169-170
    PubMedGoogle Scholar
  • 68 Ashar B, Vargo E. Shark cartilage-induced hepatitis.  Ann Intern Med . 1996;  125 780-781
    PubMedGoogle Scholar
  • 69 Park G JH, Mann S P, Ngu M C. Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum J Gastroenterol Hepatol .  2001;  16 115-117
    PubMedGoogle Scholar
  • 70 But P P, Tomlinson B, Lee K L. Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiflorum Vet Hum Toxicol .  1996;  38 280-282
    PubMedGoogle Scholar
  • 71 Steenkamp V, Stewart M, Zuckerman M. Clinical and analytical aspects of pyrrolizidine alkaloid poisoning caused by South African traditional medicines.  Ther Drug Monit . 2000;  22 302-306
    CrossrefPubMedGoogle Scholar
  • 72 De Smet P G M A, Van den Eertwegh J M A, Lesterhuis W. Hepatotoxicity associated with herbal tablets.  BMJ . 1996;  313 92
    PubMedGoogle Scholar
  • 73 Takegoshi, Tohyama T, Cox D. Hepatotoxicity associated with herbal tablets (letter).  BMJ . 1996;  313 92
    PubMedGoogle Scholar
  • 74 Zimmerman H J. Drug-induced liver disease.  Clin Liver Dis . 2000;  4 73-96
    PubMedGoogle Scholar
  • 75 Khojasteh-Bakht S C, Chen W, Koenigs L L. Metabolism of (R)+-pulegone and (R)-+-menthofuran by human liver cytochrome P450s: evidence for formation of a furan epoxide.  Drug Metab Dispos . 1999;  27 574-580
    PubMedGoogle Scholar
  • 76 Ben Yahia M, Mavier P, Metreau J M. Hépatite chronique active et cirrhose induites par la germandree petit-chêne. Trois cas.  Gastroenterol Clin Biol . 1993;  17 959-962
    PubMedGoogle Scholar
  • 77 Perharic-Walton L, Murray V. Toxicity of Chinese herbal remedies.  Lancet . 1992;  340 674
    CrossrefPubMedGoogle Scholar
  • 78 Hullar T E, Sapers B L, Ridker P M. Herbal toxicity and fatal hepatic failure.  Am J Med . 1999;  106 267-268
    CrossrefPubMedGoogle Scholar
  • 79 DeLeve L D, McCuskey R S, Wang X. Characterization of a reproducible rat model of hepatic veno-occlusive disease.  Hepatology . 1999;  29 1779-1791
    CrossrefPubMedGoogle Scholar
  • 80 Wang X, Kanel G C, DeLeve L D. Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat.  Hepatology . 2000;  31 428-434
    CrossrefPubMedGoogle Scholar
  • 81 Laliberte L, Villeneuve J P. Hepatitis after use of germander, a herbal remedy.  Can Med Assoc J . 1996;  154 1689-1692
    PubMedGoogle Scholar
  • 82 Alvarez P, Saez-Royuela F, Pena G. Acute hepatitis due to ingestion of Teucrium chamaedrys infusions.  Gastroenterol Hepatol . 2001;  24 240-243
    PubMedGoogle Scholar
  • 83 Lekehal M, Pessayre D, Lereau J M. Hepatotoxicity of the herbal medicine germander: metabolic activation of its furano diterpenoids by cytochrome P4503A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes.  Hepatology . 1996;  24 212-218
    PubMedGoogle Scholar
  • 84 De Berardinis V, Moulis C, Maurice M. Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes.  Mol Pharmacol . 2000;  58 542-551
    PubMedGoogle Scholar
  • 85 Melchart D, Linde K, Weidenhammer W. Liver enzyme elevation in patients treated with traditional Chinese medicine.  JAMA . 1999;  282 28-29
    CrossrefPubMedGoogle Scholar
  • 86 Grahan-Brown R. Toxicity of Chinese herbal remedies (letter).  Lancet . 1992;  340 673
    CrossrefPubMedGoogle Scholar
  • 87 Gorey J D, Wahlqvist M L, Boyce N W. Adverse reaction to a Chinese herbal remedy.  Med J Aust . 1992;  157 484-486
    PubMedGoogle Scholar
  • 88 Chitturi S, Farrell G C. Drug induced liver disease. In: Sorrell MF, Schiff ER, eds. Schiff's Diseases of the Liver, 9th ed Philadelphia: Lippincott Williams & Wilkins; 2002 (in press)
    Google Scholar
  • 89 Shimizu I. Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma.  J Gastroenterol Hepatol . 2000;  15(Suppl) D84-D90
    CrossrefPubMedGoogle Scholar
  • 90 MacGregor F B, Abernethy V E, Dahabra S. Hepatotoxicity of herbal remedies.  BMJ . 1989;  199 1156-1157
    PubMedGoogle Scholar
  • 91 Smith B C, Desmond P V. Acute hepatitis induced by ingestion of the herbal medicine chaparral.  Aust N Z J Med . 1993;  23 526
    CrossrefPubMedGoogle Scholar
  • 92 Strahl S, Ehret V, Dahm H H, Maier K P. Necrotizing hepatitis after taking herbal remedies.  [Article in German] Dtsch Med Wochenschr . 1998;  123 1410-1414
    Article in Thieme ConnectPubMedGoogle Scholar